Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Therapeutic Advances in Medical Oncology|February 20, 2025
Efficacy of goserelin in ovarian function suppression and preservation for pre- and perimenopausal breast cancer patients: a systematic reviewNan Chen, Daniella Audi Blotta, Hee Jeong Kim, et al.Journal of the Advanced Practitioner in Oncology|August 12, 2024
Intravenous Cetirizine Premedication to Mitigate Infusion-Related ReactionsTimothy Tyler, Erik Stojanoff, Joan Cannon, et al.The New England Journal of Medicine|November 5, 2004
Serum antibody responses after intradermal vaccination against influenzaRobert B Belshe, Frances K Newman, Joan Cannon, et al.JCO Oncology Practice|May 21, 2025
Treatment Patterns of Goserelin 3.6 mg Once Every 4 Weeks and 10.8 mg Once Every 12 Weeks in Women With Breast Cancer: A Real-World Analysis of Patients in the United StatesKelly E McCann, Virginia Kaklamani, Noran Osman, et al.Breast Cancer Research and Treatment|March 6, 2025
Goserelin 3-month depot shows non-inferiority to the monthly formulation in U.S. patients with premenopausal breast cancer: a real-world evidence studyKelly E McCann, Noran Osman, Joan Cannon, et al.Thescientificworldjournal|February 24, 2006
Amikacin dosing and monitoring in spinal cord injury patients: variation in clinical practice between spinal injury units and differences in experts' recommendationsSubramanian Vaidyanathan, Charles Peloquin, Jean-Jacques Wyndaele, et al.Movement Disorders Clinical Practice|April 6, 2019
Six-Month Use of Droxidopa for Neurogenic Orthostatic HypotensionClément François, Cyndya A Shibao, Italo Biaggioni, et al.Pageof 1